The Patent Finder

Arx, LLC

7 patents currently held · Updated Nov 21, 2026
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

  • 2 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,662,297Production of unit dose constructs
In force
 · USPTO record
In forceUSPTO record
US 9,662,301Production of unit dose constructs
In force
 · USPTO record
In forceUSPTO record
US 9,814,674Production of unit dose constructs
In force
 · USPTO record
In forceUSPTO record
US 9,545,376Production of unit dose constructs
In force
 · USPTO record
In forceUSPTO record
US 11,648,197Dispensing Method for Producing Dissolvable Unit Dose Film Constructs
In force
 · High confidence
In forceHigh confidence
US 12,268,775Dispensing method for producing dissolvable unit dose film constructs
In force
 · USPTO record
In forceUSPTO record
US 12,691,080Fenretinide Formulations, Systems Incorporating Same, and Methods for Their Use
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 7: 10 patents in force now held by others · 6 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 4 abandoned · 3 no status recorded

Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/448,754Film Formulations Containing Dexmedetomidine and Methods of Producing ThemAug 11, 2023Abandoned
18/448,640Film Formulations Containing Dexmedetomidine and Methods of Producing ThemAug 11, 2023Abandoned
18/846,426TRANSDERMAL DELIVERY SYSTEMS FOR CERTAIN FACTOR Xa INHIBITORS AND RELATED METHODS FOR THEIR PREPARATION AND USEMar 13, 2023Pending
18/085,263Film Formulations Containing Dexmedetomidine and Methods of Producing ThemDec 20, 2022Abandoned
17/628,021Non-Sedating Dexmedetomidine Treatment RegimensJul 17, 2020Abandoned
15/597,498May 17, 2017No status recorded
14/757,886Dec 23, 2015No status recorded
12/279,730Mar 6, 2007No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited